PF-06439015 mesylate T33946
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to krizotinib. Pf-06439015 is an effective selective inhibitor.
CAS nr:
1549629-82-4
Purity:
98%
Molecular Weight:
548,61
SMILES:
O[C@H](CC1=NC(C)=C(C2=CC(O[C@@H](C3=CC(F)=CC=C3N4N=CC=N4)C)=C(N)N=C2)S1)COS(C)(=O)=O
Formula:
C23H25FN6O5S2
Pathway:
Target:
